Regarding pediatric cancers, CDH6 overexpression was observed in osteosarcoma and was associated with the overall survival and prognosis of osteosarcoma patients [95], where CDH6 expression was regulated by miR-223-3p. Here, CDH6 is linked to childhood malignant neoplasm.